To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects
Clinical trial NCT03718611 · COMPLETED
Trial details
- NCT number
- NCT03718611
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2019-03-18
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.